Latest News and Press Releases

Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study

PORTLAND, Ore., May 07, 2026 (GLOBE NEWSWIRE) -- Widmer Brothers Brewing, the creator of the Original American Hefeweizen and a craft brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY),...

- Record First Quarter Revenue of $249.0 Million, Up 12.0% Year-Over-Year – - Net Income of $31.9 Million, or $0.71 Per Diluted Share – - Adjusted Net Income1 of $34.6 Million, or $0.78 Per Diluted...

Mabylon AG leveraged Asimov's lead optimization offering, Rapid Pools, to de-risk candidate selection before advancing into cell line development.

First quarter revenue grew 32% year-over-year to $1,006 million Robust growth of larger customers, with about 4,550 $100k+ ARR customers, up from about 3,770 a year ago Launched MCP Server, Bits AI...

Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates

LAS VEGAS, May 07, 2026 (GLOBE NEWSWIRE) -- AI Financial Corporation (NASDAQ:AIFC)(FRA:5AR1) ("AiFi" or the "Company"), a fintech company providing blockchain-powered payment, trading, and...

Phase 2a follow-up period data for RAP-219 in focal onset seizures (FOS) demonstrated sustained seizure reduction, including a 90% median reduction in clinical seizures over baseline in weeks 9-12  ...

VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) is pleased to provide an update on its 2026 field...

- FHD-909 (LY4050784) Phase 1 dose-escalation trial on track; preclinical combination data with anti-PD-1 antibody demonstrates potential for robust and durable regression with anti-tumor immune...